Growth Metrics

Quest Diagnostics (DGX) Tax Provisions (2016 - 2026)

Quest Diagnostics' Tax Provisions history spans 18 years, with the latest figure at $74.0 million for Q1 2026.

  • On a quarterly basis, Tax Provisions rose 25.42% to $74.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $329.0 million, a 23.68% increase, with the full-year FY2025 number at $314.0 million, up 15.02% from a year prior.
  • Tax Provisions hit $74.0 million in Q1 2026 for Quest Diagnostics, down from $81.0 million in the prior quarter.
  • Over the last five years, Tax Provisions for DGX hit a ceiling of $110.0 million in Q1 2022 and a floor of -$4.0 million in Q4 2022.
  • Historically, Tax Provisions has averaged $69.0 million across 5 years, with a median of $74.0 million in 2024.
  • Biggest five-year swings in Tax Provisions: plummeted 103.51% in 2022 and later surged 1100.0% in 2023.
  • Tracing DGX's Tax Provisions over 5 years: stood at -$4.0 million in 2022, then surged by 1100.0% to $40.0 million in 2023, then skyrocketed by 70.0% to $68.0 million in 2024, then increased by 19.12% to $81.0 million in 2025, then fell by 8.64% to $74.0 million in 2026.
  • Business Quant data shows Tax Provisions for DGX at $74.0 million in Q1 2026, $81.0 million in Q4 2025, and $77.0 million in Q3 2025.